z-logo
open-access-imgOpen Access
Concomitant Risk Factors in Reports of Torsades de Pointes Associated with Macrolide Use: Review of the United States Food and Drug Administration Adverse Event Reporting System
Author(s) -
Douglas Shaffer,
Sarah Singer,
Joyce A. Korvick,
Peter K. Honig
Publication year - 2002
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/340861
Subject(s) - torsades de pointes , medicine , concomitant , azithromycin , adverse event reporting system , qt interval , clarithromycin , food and drug administration , erythromycin , adverse effect , macrolide antibiotics , anesthesia , pharmacology , antibiotics , microbiology and biotechnology , biology , helicobacter pylori
In this case series, we examined concomitant risk factors mentioned in reports of torsades de pointes, a rare ventricular arrhythmia, that occurred in association with administration of macrolide antimicrobials (e.g., azithromycin, clarithromycin, dirithromycin, and erythromycin). Increasing age, female sex, and concomitant diseases and drug administration believed to increase risks for torsades de pointes were commonly reported.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom